A PYMNTS Company
Antitrust Chronicle<sup>®</sup> – EVERGREENING – AN EVERGREEN ANTITRUST PROBLEM

Antitrust Chronicle® – EVERGREENING – AN EVERGREEN ANTITRUST PROBLEM

Autumn 2014, Volume 11, Number 2

Dear Readers, This CPI issue focuses primarily on two segments, product hopping and pay-for-delay. In the first piece, we look (1) “product hopping” from one version of a drug to another and (2) settlements by which brands pay generics to delay entry. Then, we look at regulatory approaches in the EU and U.S. on “evergreening,” […]

Read More

In this issue

Antitrust Chronicle® – EVERGREENING – AN EVERGREEN ANTITRUST PROBLEM
CPI
Oct 4, 2021
The Rising Tide: Competition Law Enforcement in the Indian Pharmaceutical Sector
CPI
Dec 23, 2015
NOV-14(2)
CPI
Dec 23, 2015
“Good Luck” Post-Actavis: Current State of Play on “Pay-for-Delay” Settlements
Seth Silber
Nov 24, 2014
Competition Issues in the Canadian Pharmaceutical Industry
Alan Gunderson
Nov 24, 2014
“Product Hopping” on Both Sides of the Pond: A Survey of U.S. and EU Case Law
Ingrid Vandenborre
Nov 24, 2014
Pharmaceutical Antitrust Complexity
Michael Carrier
Nov 24, 2014

In case you missed it...

See more Chronicles by year:

Featured News

President Trump’s Media Investments Stir Ethics Questions After Netflix–Warner Bros. Deal
Jan 19, 2026 by

Elon Musk Seeks Billions in Damages From OpenAI and Microsoft as Legal Fight Heads to Trial
Jan 19, 2026 by

Italy’s Leonardo Chairman Floats Possible Merger With Fincantieri
Jan 19, 2026 by

Spanish Competition Authority Clears Naver’s Takeover of Wallapop
Jan 19, 2026 by

As Companies Move From AI Testing to Implementation, Compliance Takes Center Stage
Jan 19, 2026 by